Download PDF
Thromb Haemost 2000; 83(04): 589-591
DOI: 10.1055/s-0037-1613868
Commentary
Schattauer GmbH

The Thrombogram: Monitoring Thrombin Generation in Platelet Rich Plasma

Coenraad H. Hemker
2   Department of Biochemistry and Synapse BV, Cardiovascular Research Institute (CARIM) Maastricht, The Netherlands
,
Peter L. A. Giesen
2   Department of Biochemistry and Synapse BV, Cardiovascular Research Institute (CARIM) Maastricht, The Netherlands
,
Manoj Ramjee
1   Peptide Therapeutics Ltd., Cambridge, United Kingdom
,
Rob Wagenvoord
2   Department of Biochemistry and Synapse BV, Cardiovascular Research Institute (CARIM) Maastricht, The Netherlands
,
Suzette Béguin
2   Department of Biochemistry and Synapse BV, Cardiovascular Research Institute (CARIM) Maastricht, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 20 July 1999

Accepted after revision 23 November 1999

Publication Date:
08 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

A method is described in which thrombin activity in clotting plasma can be monitored through the continuous measurement of the fluorescent split-product of the substrate Z-Gly-Gly-Arg-AMC. The signal is not impaired by turbidity; therefore proper measurement is not disturbed by the occurrence of a clot or the presence of platelets and direct measurement in platelet rich plasma is possible.

Keywords

Thrombin generation - thrombin potential - thrombogram - platelet rich plasma
 

  • References

  • 1 Hemker HC, Wielders S, Kessels H, Béguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-24.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Biggs R, Macfarlane RG. Human Blood Coagulation and its Disorders. Blackwell Scientific Publications; Oxford 1953.:
    Google Scholar
  • 3 Seegers W. Prothrombin. Harvard University Press: Cambridge Mass; 1962
    Google Scholar
  • 4 Béguin S, Kumar R. Thrombin, fibrin and platelets: a resonance loop in which von Willebrand factor is a necessary link. Thromb Haemost 1997; 78: 590-4.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Béguin S, Lindhout T, Hemker HC. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin. Thromb Haemost 1989; 61: 25-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Hemker HC, Willems GM, Béguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56: 9-17.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Hemker HC, Béguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost 1995; 74: 134-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Neri GGSerneri, Rovelli F, Gensini GF, Pirelli S, Carnovali M, Fortini A. Effectiveness of low-dose heparin in prevention of myocardial reinfarction. Lancet 1987; 01: 937-42.
    PubMedGoogle Scholar
  • 9 A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Report of the Sixty Plus Reinfarction Study Research Group. Lancet 1980; 02: 989-94.
    PubMedGoogle Scholar
  • 10 Agnelli G. Thrombin plays a pivotal role in vascular re-occlusion after PTCA and coronary thrombolysis. Cardiovasc Res 1996; 31: 232-4.
    CrossrefPubMedGoogle Scholar
  • 11 Badimon L, Meyer BJ, Badimon JJ. Thrombin in arterial thrombosis. Haemostasis 1994; 24: 69-80.
    PubMedGoogle Scholar
  • 12 Chesebro JH, Zoldhelyi P, Badimon L, Fuster V. Role of thrombin in arterial thrombosis: implications for therapy. Thromb Haemost 1991; 66: 1-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Heras M, Chesebro JH, Penny WJ, Bailey KR, Badimon L, Fuster V. Effects of thrombin inhibition on the development of acute plateletthrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 1989; 79: 657-65.
    CrossrefPubMedGoogle Scholar
  • 14 Jang IK, Gold HK, Ziskind AA, Leinbach RC, Fallon JT, Collen D. Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition. Circulation 1990; 81: 219-25.
    CrossrefPubMedGoogle Scholar
  • 15 Reverter JC, Béguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and “clinical restenosis”. J Clin Invest 1996; 98: 863-74.
    CrossrefPubMedGoogle Scholar
  • 16 Béguin S, Kumar R, Keularts I, Seligsohn U, Coller BS, Hemker HC. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999; 93: 564-70.
    PubMedGoogle Scholar
  • 17 Szczeklik A, Musial J, Dropinski J, Krzanowski M, Krolikowski W, Undas A, Swadzba J, Duplaga M, Bodzon W. Thrombinogenesis and its pharmacological modulation in atherosclerosis. J Physiol Pharmacol 1994; 45: 3-11.
    PubMedGoogle Scholar
  • 18 Keularts IM, Béguin S, de Zwaan C, Hemker HC. Treatment with a GPIIb/ IIIa antagonist inhibits thrombin generation in PRP from patients. Thromb Haemost 1998; 80: 370-1.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Hérault JP, Peyrou V, Savi P, Bernat A, Herbert J-M. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo. Thromb Haemost 1998; 79: 383-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Hérault J-P, Dol F, Gaich C, Bernat A, Herbert J-M. Effect of Clopidogrel on thrombin generation in platelet-rich plasma in the rat. Thromb Haemost 1999; 81: 957-60.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Faber K. Thrombotic tendency in young stroke patients. The thrombin potential as a screening parameter for coagulation disturbances. Thesis Universiteit Maastricht. 1998 ISBN 90-9012009-2.
    PubMedGoogle Scholar
  • 22 Pekelharing CA. Untersuchungen über das Fibrinferment. Verhandelingen der Koninklijke akademie van Wetenschappen (Reports of the Royal Academy of Sciences) Amsterdam. Tweede sectie 1893; 01: 3-52.
    PubMedGoogle Scholar
  • 23 Wielders S, Mukherjee M, Michiels J, Rijkers DT, Cambus JP, Knebel RW, Kakkar V, Hemker HC, Béguin S. The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability. Thromb Haemost 1997; 77: 629-36.
    Article in Thieme ConnectPubMedGoogle Scholar